What is ESLA's current stock price?

ESLA (Estrella Immunopharma, Inc.) is currently trading at $1.16 with a market cap of $49.9M.

What sector is Estrella Immunopharma, Inc. in?

Estrella Immunopharma, Inc. (ESLA) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

ESLA Estrella Immunopharma, Inc.

Healthcare

$1.16+2.65%ClosedMarket Cap: $49.9M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

-9.27

P/S

0.00

EV/EBITDA

-3.65

DCF Value

$0.02

FCF Yield

-16.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

167.9%

ROA

-362.3%

ROIC

249.4%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$0.00	$-2.3M	$—
Q4 null	$0.00	$-613.2K	$—
FY null	$0.00	$-13.1M	$—
Q3 null	$0.00	$-4.8M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

D. Boral CapitalBuy

2026-02-09

D. Boral CapitalBuy

2025-11-03

D. Boral CapitalBuy

2025-08-12

D. Boral CapitalBuy

2025-06-03

Trading Activity

Insider Trades

View All

Xu Jiandongofficer: Chief Financial Officer

BuyWed Apr 29

Xu Jiandongofficer: Chief Financial Officer

BuyWed Apr 29

Jia Dengyaodirector:

SellWed Oct 01

Xu Jiandongofficer: Chief Financial Officer

SellFri Feb 14

Xu Jiandongofficer: Chief Financial Officer

SellFri Feb 14

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

0.98

Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.

Peers

TIL